These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38979358)

  • 1. Targeting dendritic cell-specific TNFR2 improves skin and joint inflammation by inhibiting IL-12/ IFN-γ pathways in a mouse model of psoriatic arthritis.
    Kaur R; Harvey JM; Brambilla R; Chandrasekharan UM; Elaine Husni M
    bioRxiv; 2024 Jun; ():. PubMed ID: 38979358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFR2 Depletion Reduces Psoriatic Inflammation in Mice by Downregulating Specific Dendritic Cell Populations in Lymph Nodes and Inhibiting IL-23/IL-17 Pathways.
    Chandrasekharan UM; Kaur R; Harvey JE; Braley C; Rai V; Lee M; de Windt N; Hsieh J; Jaini R; Bayik D; Scheraga RG; Fernandez AP; DiCorleto PE; Husni ME
    J Invest Dermatol; 2022 Aug; 142(8):2159-2172.e9. PubMed ID: 35090950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk.
    Xu J; Chakrabarti AK; Tan JL; Ge L; Gambotto A; Vujanovic NL
    Blood; 2007 Apr; 109(8):3333-41. PubMed ID: 17164346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual neutralization of TNFR-2 and MMP-2 regulates the severity of S. aureus induced septic arthritis correlating alteration in the level of interferon gamma and interleukin-10 in terms of TNFR2 blocking.
    Sultana S; Dey R; Bishayi B
    Immunol Res; 2018 Feb; 66(1):97-119. PubMed ID: 29218573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition.
    Feng Y; Teitelbaum DH
    J Physiol; 2013 Aug; 591(15):3709-23. PubMed ID: 23753529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-α Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2.
    Pesce B; Ribeiro CH; Larrondo M; Ramos V; Soto L; Catalán D; Aguillón JC
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of TNFR1 and TNFR2 in the development of imiquimod-induced mouse psoriasis.
    Chen S; Lin Z; Xi L; Zheng Y; Zhou Q; Chen X
    J Leukoc Biol; 2021 Dec; 110(6):1047-1055. PubMed ID: 34494306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production.
    Markel TA; Crisostomo PR; Wang M; Herring CM; Meldrum DR
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G657-62. PubMed ID: 17640973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of TNF-alpha receptors influences mesenchymal stem cell-mediated cardiac protection against ischemia.
    Tan J; Weil BR; Abarbanell AM; Wang Y; Herrmann JL; Dake ML; Meldrum DR
    Shock; 2010 Sep; 34(3):236-42. PubMed ID: 20160664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia.
    Kelly ML; Wang M; Crisostomo PR; Abarbanell AM; Herrmann JL; Weil BR; Meldrum DR
    Shock; 2010 Jun; 33(6):602-7. PubMed ID: 19953003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
    Kondo S; Sauder DN
    Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain.
    Geis C; Graulich M; Wissmann A; Hagenacker T; Thomale J; Sommer C; Schäfers M
    Neuroscience; 2010 Aug; 169(1):463-74. PubMed ID: 20417692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2.
    Maney NJ; Reynolds G; Krippner-Heidenreich A; Hilkens CMU
    J Immunol; 2014 Nov; 193(10):4914-4923. PubMed ID: 25288570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.
    Guo G; Morrissey J; McCracken R; Tolley T; Klahr S
    Am J Physiol; 1999 Nov; 277(5):F766-72. PubMed ID: 10564241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Therapeutic Effect of Tacrolimus in a Mouse Psoriatic Model is Associated with the Induction of Myeloid-derived Suppressor Cells.
    Chen S; Liao P; Xi L; Yang Y; Wu W; Islam MS; Lin Z; Zheng Y; Chen X
    Rheumatol Immunol Res; 2022 Dec; 3(4):190-197. PubMed ID: 36879838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways.
    Markel TA; Crisostomo PR; Wang M; Wang Y; Lahm T; Novotny NM; Tan J; Meldrum DR
    Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1124-30. PubMed ID: 18685063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy.
    Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K
    BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFR1 and TNFR2 differentially mediate TNF-α-induced inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes.
    Zhang H; Xiao W
    Cell Biol Int; 2017 Apr; 41(4):415-422. PubMed ID: 28150360
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Larid G; Delwail A; Dalle T; Vasseur P; Silvain C; Jégou JF; Morel F; Lecron JC; Gervais E
    Front Immunol; 2022; 13():993363. PubMed ID: 36426370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.